Free Trial

Insmed (INSM) News Today

→ Trump convicted... now what? (From Stansberry Research) (Ad)
Free INSM Stock Alerts
$56.85
-0.32 (-0.56%)
(As of 06/7/2024 08:52 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 9 at 10:53 AM | marketbeat.com
Seven Eight Capital LP Raises Position in Insmed Incorporated (NASDAQ:INSM)
Seven Eight Capital LP grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 85.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,777 shares of the biopharmaceutical compa
June 8 at 4:28 PM | marketbeat.com
Insmed Incorporated (NASDAQ:INSM) Position Reduced by Sectoral Asset Management Inc.
Sectoral Asset Management Inc. cut its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 96.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,811 shares of the biopharmaceutical
June 8 at 1:38 AM | americanbankingnews.com
Insmed Incorporated (NASDAQ:INSM) to Post FY2024 Earnings of ($4.59) Per Share, Cantor Fitzgerald Forecasts
June 7 at 8:24 AM | americanbankingnews.com
Mizuho Boosts Insmed (NASDAQ:INSM) Price Target to $82.00
June 7 at 8:00 AM | prnewswire.com
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 7 at 6:24 AM | marketbeat.com
FY2024 EPS Estimates for Insmed Incorporated (NASDAQ:INSM) Decreased by Analyst
Insmed Incorporated (NASDAQ:INSM - Free Report) - Analysts at Cantor Fitzgerald cut their FY2024 earnings estimates for shares of Insmed in a research report issued on Tuesday, June 4th. Cantor Fitzgerald analyst J. Kim now expects that the biopharmaceutical company will earn ($4.59) per share fo
June 6, 2024 | marketbeat.com
Insmed (NASDAQ:INSM) Reaches New 1-Year High at $58.99
Insmed (NASDAQ:INSM) Reaches New 12-Month High at $58.99
June 5, 2024 | marketbeat.com
Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Rafferty Asset Management LLC
Rafferty Asset Management LLC lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 17.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 321,087 shares of the biopharmaceutical
June 5, 2024 | prnewswire.com
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 4, 2024 | marketbeat.com
TD Asset Management Inc Sells 59,600 Shares of Insmed Incorporated (NASDAQ:INSM)
TD Asset Management Inc cut its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 463,532 shares of the biopharmace
June 3, 2024 | marketbeat.com
Campbell & CO Investment Adviser LLC Makes New $1.70 Million Investment in Insmed Incorporated (NASDAQ:INSM)
Campbell & CO Investment Adviser LLC acquired a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 54,928 shares of the biopharmaceutical company's stock, value
June 2, 2024 | marketbeat.com
Eagle Asset Management Inc. Has $17 Million Position in Insmed Incorporated (NASDAQ:INSM)
Eagle Asset Management Inc. lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 548,633 shares of the biopharmac
June 2, 2024 | marketbeat.com
Insmed Incorporated (NASDAQ:INSM) Short Interest Up 16.4% in May
Insmed Incorporated (NASDAQ:INSM - Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 9,930,000 shares, an increase of 16.4% from the April 30th total of 8,530,000 shares. Based on an average daily trading volume, of 1,760,000 shares, the days-to-cover ratio is currently 5.6 days.
June 2, 2024 | americanbankingnews.com
Insider Selling: Insmed Incorporated (NASDAQ:INSM) Insider Sells 21,195 Shares of Stock
June 2, 2024 | americanbankingnews.com
Insmed Incorporated (NASDAQ:INSM) Insider Sells $390,951.08 in Stock
June 2, 2024 | americanbankingnews.com
Insider Selling: Insmed Incorporated (NASDAQ:INSM) CFO Sells $11,028,200.00 in Stock
June 2, 2024 | americanbankingnews.com
Insmed Incorporated to Post FY2025 Earnings of ($3.54) Per Share, HC Wainwright Forecasts (NASDAQ:INSM)
June 2, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) Stock Price Down 5.6% Following Insider Selling
June 1, 2024 | marketbeat.com
Axiom Investors LLC DE Purchases Shares of 60,027 Insmed Incorporated (NASDAQ:INSM)
Axiom Investors LLC DE acquired a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 60,027 shares of the biopharmac
June 1, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) PT Raised to $67.00 at Stifel Nicolaus
June 1, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) Sees Large Volume Increase Following Analyst Upgrade
May 31, 2024 | marketbeat.com
Insmed (NASDAQ:INSM) Trading Down 5.6% on Insider Selling
Insmed (NASDAQ:INSM) Stock Price Down 5.6% on Insider Selling
May 31, 2024 | marketbeat.com
Insmed (NASDAQ:INSM) Given New $67.00 Price Target at Stifel Nicolaus
Stifel Nicolaus boosted their target price on shares of Insmed from $39.00 to $67.00 and gave the company a "buy" rating in a research note on Friday.
May 31, 2024 | insidertrades.com
Insmed Incorporated (NASDAQ:INSM) Insider John Drayton Wise Sells 7,852 Shares
May 31, 2024 | marketbeat.com
FY2025 EPS Estimates for Insmed Incorporated (NASDAQ:INSM) Decreased by HC Wainwright
Insmed Incorporated (NASDAQ:INSM - Free Report) - Analysts at HC Wainwright lowered their FY2025 earnings per share (EPS) estimates for shares of Insmed in a research report issued to clients and investors on Wednesday, May 29th. HC Wainwright analyst A. Fein now expects that the biopharmaceutica
May 31, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) Shares Gap Down to $48.06
May 31, 2024 | americanbankingnews.com
The Goldman Sachs Group Increases Insmed (NASDAQ:INSM) Price Target to $74.00
May 31, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) PT Raised to $68.00
May 31, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) PT Raised to $55.00 at JPMorgan Chase & Co.
May 31, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) PT Raised to $63.00
May 31, 2024 | americanbankingnews.com
UBS Group Increases Insmed (NASDAQ:INSM) Price Target to $58.00
May 31, 2024 | americanbankingnews.com
Insmed (NASDAQ:INSM) PT Raised to $77.00 at Wells Fargo & Company
May 31, 2024 | americanbankingnews.com
TD Cowen Increases Insmed (NASDAQ:INSM) Price Target to $67.00
May 30, 2024 | marketbeat.com
Insider Selling: Insmed Incorporated (NASDAQ:INSM) Insider Sells 7,852 Shares of Stock
Insmed Incorporated (NASDAQ:INSM - Get Free Report) insider John Drayton Wise sold 7,852 shares of the company's stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $49.79, for a total transaction of $390,951.08. Following the sale, the insider now directly owns 121,657 shares in the company, valued at $6,057,302.03. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
May 30, 2024 | prnewswire.com
Insmed to Host Commercial Webinar on June 4, 2024
May 30, 2024 | prnewswire.com
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
May 30, 2024 | marketbeat.com
Norges Bank Invests $45.03 Million in Insmed Incorporated (NASDAQ:INSM)
Norges Bank bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,453,025 shares of the biopharmaceutica
May 29, 2024 | marketwatch.com
Insmed Shares Extend Gains, Reach 23-Year High
May 29, 2024 | finance.yahoo.com
Insmed PT Raised to $67 at TD Cowen
May 29, 2024 | marketbeat.com
Insmed (NASDAQ:INSM) Price Target Raised to $67.00 at TD Cowen
TD Cowen upped their target price on shares of Insmed from $45.00 to $67.00 and gave the company a "buy" rating in a research note on Wednesday.
May 29, 2024 | msn.com
Insmed’s stock should triple after positive drug trial data, analyst says
May 29, 2024 | markets.businessinsider.com
Buy Rating on Insmed: Anticipating Growth and Increased Stock Value
May 29, 2024 | markets.businessinsider.com
Insmed’s Promising Future: A Buy Rating with Increased Price Target Post-ASPEN Trial Success
May 28, 2024 | finance.yahoo.com
Insmed stock blasts off over lung condition study results
May 28, 2024 | msn.com
Insmed Stock More Than Doubled in Value Tuesday—Here’s Why
May 28, 2024 | prnewswire.com
Insmed Announces Proposed $500 Million Public Offering of Common Stock
May 28, 2024 | investopedia.com
Insmed Stock More Than Doubled in Value Tuesday—Here's Why
May 28, 2024 | finance.yahoo.com
Insmed Shares Rocket After Drug Eases Lung Disease Symptoms
May 28, 2024 | seekingalpha.com
Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)
May 28, 2024 | msn.com
Insmed Stock More Than Doubles on Trial Win for Lung-Condition Drug
Get Insmed News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter.

Trump convicted... now what? (Ad)

Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next.

Which is why it's so important to access this presentation while it's still available online.

INSM Media Mentions By Week

INSM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INSM
News Sentiment
▼
0.64

0.76
▲
Average
Medical
News Sentiment

INSM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INSM Articles
This Week
▼
15

5
▲
INSM Articles
Average Week

Get Insmed News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:INSM) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Alert: Your Bank is Dying – Act Now or Lose Everything!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...
Priority Gold | Sponsored
Trump convicted... now what?
Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...
Stansberry Research | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored